-
Benton DJ, Gamblin SJ, Rosenthal PB, Skehel JJ, et al.
Structural transitions in influenza haemagglutinin at membrane fusion pH. Nature 2020.
-
Rudin CM, Awad MM, Navarro A, Gottfried M, et al.
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for
Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III
KEYNOTE-604 Study. J Clin Oncol 2020.
-
Heinzel S, Aho VTE, Suenkel U, von Thaler AK, et al.
Gut microbiome signatures of risk and prodromal markers of Parkinson's disease. Ann Neurol 2020.
-
Fantini ML, Fedler J, Pereira B, Weintraub D, et al.
Is RBD a risk factor for impulse control disorder in Parkinson's disease? Ann Neurol 2020.
-
Reck M, Wehler T, Orlandi F, Nogami N, et al.
Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or
Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung
Cancer. J Clin Oncol 2020.
|